ERBB2 and lung adenocarcinoma: Buttitta et al diagnosed HER2 gene mutations in 9 out of 403 Caucasian patients with lung adenocarcinoma (2.2%), but only 7 mutations were determined to be an insertion of 12 nucleotide pairs in exon 20.